The development of new drugs, which requires compliance with relevant laws, cannot be sustainable without knowledge of a sequence of clinical trials of drugs, commercialization of products, and follow-up survey after distribution. The author, an expert involved with the exploitation of new drugs for years, comments on the necessity of regulations and control, as well as details of the development. A valuable companion to those concerned with pharmaceutical research and sales.